Mpox (MONKEYPOX)

P R E S E N TAT I O N B Y H E N N I N G A N S O R G , M . D . , H E A LT H O F F I C E R
S A N TA B A R B A R A C O U N T Y P U B L I C H E A LT H D E PA R T M E N T
Clinical Presentation
•The MPox virus is a member of the Orthopoxvirus family (Smallpox). Endemic in few West and
Central African countries, most likely through infected rodent bites
• Transmitted through close skin lesion to skin contact or prolonged face to face contact via
respiratory droplets or contaminated materials such as bedding
MPox is NOT spread through:
◦ Casual brief conversations
◦ Walking by someone with monkeypox, like in a grocery store
•Incubation period average 7-14 days (non-contagious during this period)
•Flu-like symptoms (fever, headache, muscle ache), fatigue, and lymphadenopathy

• Rash typically develops after the fever; can last 2-4 weeks
Local Epidemiology
•Confirmed Cases as of August 12, 2022: 5

•Suspect Cases Evaluated: 24

•Contacts to Confirmed Cases Evaluated: 40

•Vaccinations Administered: 35
 California MPox Cases as of August 9, 2022
1733 confirmed/probable cases
+598 increase since last report (8/2)

30 local health jurisdictions

+ 2 since last report (8/2)

36 hospitalizations
+ 22 since last report (8/2)

No deaths
Risks and Precautions
•The risk to the general population is very low
•MPox is much less contagious than COVID-19
•This virus is spread by prolonged skin to skin contact or via droplets during close
face to face contact (kissing, cuddling)
•Avoid intimate contacts with persons who have skin lesions
•Limit the number of intimate partners
•Disclose to partners if you experience any symptoms or have skin lesion(s)
 Treatment for severe cases

Tecovirimat (TPOXX)- Expanded Access/Investigational Use

Only:
• Priority: Severe or at-risk for severe MPox disease
•10 courses (oral) available for use in Santa Barbara County
Vaccination
Jynneos Vaccine for Prevention of disease:
•220 regular doses available for high risk groups and for
post exposure prophylaxis of contacts
•FDA granted EUA on August 9, 2022 for use of 1/5 of a
regular dose given intradermally
• Which means 1,100 available doses based on EUA
◦ Vaccine is being distributed to infectious disease clinics
and other entities to protect the most at-risk population
Outreach & Vaccination
◦ MPX Community Town Hall (8/17) with
Pacific Pride Foundation
◦ Including Dr Ansorg, Dr. Fenzi,
Dr. Fitzgibbons among others as panelists

◦ Special vaccination events by PHD in

cooperation with PPF, Planned
Parenthood are being coordinated for
North and South County
Risks and Precautions
•The risk to the general population is very low
•MPox is much less contagious than COVID-19
•This virus is spread by prolonged skin to skin contact or via droplets during close
face to face contact (kissing, cuddling)
•Avoid intimate contacts with persons who have skin lesions
•Limit the number of intimate partners
•Disclose to partners if you experience any symptoms or have skin lesion(s)
Thank You
EUA for intradermal use of smaller dose
of Jynneos scientific background
Risks and Precautions
•The risk to the general population is very low.
•Monkeypox is much less contagious than COVID-19.
•This virus is spread by prolonged skin to skin contact or via droplets during close
face to face contact (kissing, cuddling).
•Avoid intimate contacts with persons who have skin lesions.
•Limit the number of intimate partners
•Disclose to partners if you experience any symptoms or have skin lesion(s)